KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Cash & Current Investments (2016 - 2025)

Novartis Ag's Cash & Current Investments history spans 13 years, with the latest figure at $2.7 billion for Q4 2025.

  • On a quarterly basis, Cash & Current Investments rose 19.51% to $2.7 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $2.7 billion, a 19.51% increase, with the full-year FY2025 number at $2.7 billion, up 19.51% from a year prior.
  • Cash & Current Investments hit $2.7 billion in Q4 2025 for Novartis Ag, down from $11.5 billion in the prior quarter.
  • Over the last five years, Cash & Current Investments for NVS hit a ceiling of $28.3 billion in Q4 2021 and a floor of $5117.0 in Q2 2021.
  • Historically, Cash & Current Investments has averaged $7.0 billion across 5 years, with a median of $2.5 billion in 2024.
  • Biggest five-year swings in Cash & Current Investments: plummeted 100.0% in 2021 and later surged 270705391.5% in 2022.
  • Tracing NVS's Cash & Current Investments over 5 years: stood at $28.3 billion in 2021, then plummeted by 33.18% to $18.9 billion in 2022, then decreased by 23.78% to $14.4 billion in 2023, then tumbled by 84.47% to $2.2 billion in 2024, then rose by 19.51% to $2.7 billion in 2025.
  • Business Quant data shows Cash & Current Investments for NVS at $2.7 billion in Q4 2025, $11.5 billion in Q2 2025, and $2.2 billion in Q4 2024.